Tue, 16th Sep 2014 17:28
** Biotechnology company's shares up 3 pct at$13.94
** U.S. FDA approves oral therapy to treat opioid-inducedconstipation, co-developed with AstraZeneca Plc
** The drug will be sold under the trade name Movantik, andbe launched in the first half of 2015, the companies said
** Up to Monday's close, stock had gained about 19 pct thisyear
(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expe...
(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugat...
(Alliance News) - London's FTSE 100 is called to open higher at the start of the week, while the pound climbed and gold hit another record high, with ...
(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of ant...
(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.
Astrazeneca (AZN)